Top compounds associated with response to CCNE2


Feature Type Standardized
Nominal ANOVA
mRNA PL-DI CTRPv2 pan-cancer AAC 0.13 3e-05
mRNA BRD-K13999467 CTRPv2 pan-cancer AAC 0.15 4e-05
mRNA TG-100-115 CTRPv2 pan-cancer AAC 0.16 4e-05
mRNA CIL41 CTRPv2 pan-cancer AAC 0.21 4e-05
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 6e-05
mRNA RO-3306 GDSC1000 pan-cancer AAC -0.14 6e-05
mRNA Erlotinib CTRPv2 pan-cancer AAC -0.14 6e-05
mRNA Topotecan CCLE pan-cancer AAC 0.17 7e-05
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 7e-05
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 7e-05
Download CSV